U.S. Politicians Sell This Pharmaceutical Stock Days Prior to Trump’s Drug Pricing Order
Summary
⚈ Two U.S. lawmakers sold AbbVie shares shortly before Trump’s drug price-cutting announcement, raising concerns about potential insider knowledge.
⚈ Trump’s May 13 executive order targets up to 80% reductions in drug costs, directly impacting companies like AbbVie.
⚈ The trades took place during broader market volatility tied to tariff-related fallout, adding to the controversy.
Receive Signals on US Congress Members’ Stock Trades
Although there is no evidence of wrongdoing on the lawmakers’ part, the timing of the sales raises suspicion of potential insider knowledge, as they may have been privy to discussions likely to impact the stock market. Adding to concerns is the fact that the trades also occurred amid tariff-induced market volatility following the April 2 ‘Liberation Day’ fallout.
On May 11, Trump announced plans to sign an executive order on May 13 to cut drug prices by 30% to 80% through a “most favored nation” policy, ensuring the U.S. pays the lowest global price. He also accused drug companies of exploiting consumers and dismissed high research and development costs.
In this context, if the executive order is implemented without opposition, it will likely significantly impact the revenue of companies like AbbVie, which rely heavily on the U.S. market for profits. In Q1 2025, the biomedical firm reported $13.3 billion in revenue, an 8.4% year-over-year increase. At the same time, AbbVie has long been criticized for high drug prices, particularly for its Humira, a drug for rheumatoid arthritis.
As expected, ABBV stock took a hit in pre-market trading following Trump’s announcement, falling 4% to $177. The stock had closed the previous session down 0.5% at $184, but still maintains modest year-to-date gains of 2.88%.
Indeed, the executive order compounds matters for AbbVie, which is already attempting to improve profit margins, currently down by double digits, with an 11% year-over-year decline for Q1 2025.